Pothast, C. R., Hofsink, Q., Haggenburg, S., Dijkland, R. C., Meent, M. v. d., Dijk, K. v., . . . team, C. K. s. T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationPothast, Cilia R., et al. T-cell and Antibody Responses in Immunocompromised Patients with Hematologic Malignancies Indicate Strong Potential of SARS-CoV-2 MRNA Vaccines. Ferrata Storti Foundation.
MLA (9th ed.) CitationPothast, Cilia R., et al. T-cell and Antibody Responses in Immunocompromised Patients with Hematologic Malignancies Indicate Strong Potential of SARS-CoV-2 MRNA Vaccines. Ferrata Storti Foundation.
Warning: These citations may not always be 100% accurate.